Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

81.63
Delayed Data
As of Aug 26
 +0.09 / +0.11%
Today’s Change
35.83
Today|||52-Week Range
120.94
+17.55%
Year-to-Date
Why You Should (and Shouldn't) Buy GW Pharmaceuticals Plc
Aug 26 / MotleyFool.com - Paid Partner Content
Cardiovascular Systems (CSII) Catches Eye: Stock Up 5.6%
Aug 23 / Zacks.com - Paid Partner Content
Medtronic (MDT) Beats Q1 Earnings, Revenues Closely In-Line
Aug 25 / Zacks.com - Paid Partner Content
2 Big Back-Alley Brawls Break Out in Washington Over Policy
Aug 23 / MotleyFool.com - Paid Partner Content
TG Therapeutics (TGTX) Catches Eye: Stock Jumps 9.2%
Aug 25 / Zacks.com - Paid Partner Content
Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Aug 19 / Zacks.com - Paid Partner Content
Will GW Pharmaceuticals (GWPH) Crush Estimates at Its Next Earnings Report?
Aug 24 / Zacks.com - Paid Partner Content
3 Reasons GW Pharmaceuticals' Stock Could Rise
Aug 17 / MotleyFool.com - Paid Partner Content
Medtronic's HeartWare Takeover Complete for $1.1 Billion
Aug 24 / Zacks.com - Paid Partner Content
Phibro (PAHC) Focuses on Growth Amid Pricing Pressure
Aug 17 / Zacks.com - Paid Partner Content
Phibro Animal Health: Currency & Competition Woes Persist
Aug 23 / Zacks.com - Paid Partner Content
Zimmer Biomet Acquires CD Diagnostics, Targets PJI Market
Aug 17 / Zacks.com - Paid Partner Content
Illumina Rallies on Rumors of Takeover by Thermo Fisher
Aug 23 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for August 15th
Aug 15 / Zacks.com - Paid Partner Content